Topotecan (hycamtin) in the therapy of recurrent ovarian carcinoma

Onkologie

Volumn 21, Issue SUPPL. 4, 1998, Pages 2-5

  Mobus V ^a,b   Pfaff, P N ^a   Kreienberg, R ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Long term topotecan therapy; Ovarian cancer; Topotecan

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; PLATINUM DERIVATIVE; TOPOTECAN;

ALOPECIA; ANEMIA; BLOOD TOXICITY; CANCER REGRESSION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; NAUSEA; NEUTROPENIA; OVARY CARCINOMA; RECURRENT CANCER; THROMBOCYTOPENIA; VOMITING;

EID: 0032417760     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054975     Document Type: Conference Paper

References (6)

1. Hoechster H, Speyer J, Wadler S, Runowitz C, Wallach R, Oratz R, Chachoua A, Sorich J, Taubes B, Ludwig E, Broom C: Activity of topotecan 21-day infusion in platinum treated ovarian cancer and pharmacodynamics of topo-1 depletion. Ann Oncol 1996;7(suppl).
2. Creemers GJ, Bolis G, Gore M, Scarane G, Lacave AJ, Guastalla JP, Despax R, Favalli G, Kreienberg R, van Belle S, Hudson I, Verweij J, ten Bokkel Huinink W: Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: Results of a large European phase II study. J Clin Oncol 1996;14: 3056-3061.
3. Gordon A, Bookman M, Malmstrom H, Bolis G, Mangioni C, Hall J, Carter J, Hudson I, Broom C: Efficacy of topotecan in advanced epithelial ovarian cancer after failure of platinum and paclitaxel: International Topotecan Study Group trial. Proc Am Soc Clin Oncol 1996;15:763.
4. Ten Bokkel Huinink W, Gore M, Carmichael J, Gordon A, Malfetano J, Hudson I, Broom C, Carabelli C, Davidson N, Spanczynski M, Bolis G, Malmström H, Coleman R, Fields SC, Heron JF: Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J Clin Oncol 1997;15:2183-2193.
5. Ganem G, Gladieff L, Guastalla JP, Benbunan JJ, Kanoui A, Assouline D, Walter S, Combe M, Guichard F, Pujade-Lauraine E: Sequential topotecan and etoposide in pretreated ovarian cancer patients. A GINECO phase II study. Proc Am Soc Clin Oncol 1998;17:1371.
6. Kudelka AP, Tresukosol D, Edwards CL, Freedman RS, Levenback C, Chantarawiroj P, Gonzales de Leon C, Kim EE, Madden T, Wallin B, Hard M, Verschraegen C, Raber M, Kavanagh J: Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma. J Clin Oncol 1996;14:1552-1557.